Raymond James Financial Inc. Buys Shares of 21,774 Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Raymond James Financial Inc. purchased a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,774 shares of the biopharmaceutical company’s stock, valued at approximately $916,000. Several other large investors have also recently […]
Raymond James Financial Inc. purchased a new stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,774 shares of the biopharmaceutical company’s stock, valued at approximately $916,000. Several other large investors have also recently […]
